XML 110 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Cash Flows from Operating Activities        
Net (loss) income $ (8,736,845) $ 6,441,842    
Adjustment to reconcile net (loss) income to cash (used in) provided by operating activities        
Depreciation and amortization 1,310,720 1,366,720    
Gain on disposal of fixed assets (91,684)    
Change in fair value of warrant liabilities (828,000)    
Provision for credit losses 2,282,588 967,148    
Noncash operating lease expense 523,821 399,610    
Noncash finance lease expense 102,354 64,762    
Stock based compensation expense 7,101,818    
Changes in operating assets and liabilities:        
Accounts receivable (7,864,274) (7,186,538)    
Accounts receivable due from related parties (36,410)    
Inventories (131,898) 34,530    
Prepaid installation costs 3,842,974    
Prepaids and other current assets (689,656) (322,568)    
Other assets (254,806) (566,075)    
Due from related party (94,056)    
Accounts payable (437,190) 3,223,485    
Accrued expenses and other current liabilities (1,195,659) 885,228    
Accrued expenses and other current liabilities due to related parties (1,985,281)    
Contract liabilities (3,460,989) 842,150    
Contract liabilities due to related parties (1,160,848)    
Operating lease payments (480,270) (389,890)    
Net cash (used in) provided by operating activities (12,189,535) 5,666,348    
Cash flows from Investing Activities        
Purchases of property, equipment and other assets (285,067) (161,768)    
Net cash used in investing activities (285,067) (161,768)    
Cash flows from Financing Activities        
Proceeds from the issuance of debt 192,210    
Repayments of finance lease liabilities (87,728) (56,822)    
Proceeds from the issuance of convertible preferred stock, net of transaction costs 9,221,649    
Repayments of debt (261,563) (272,736)    
Distributions to members (90,000) (3,289,518)    
Net cash provided by (used in) financing activities 8,782,358 (3,426,866)    
Net (decrease) increase in cash and cash equivalents (3,692,244) 2,077,714    
Cash and cash equivalents, beginning of period 8,022,306 2,268,306 $ 2,268,306  
Cash and cash equivalents, end of the period 4,330,062 4,346,020 8,022,306 $ 2,268,306
Supplemental Cash Flow Information        
Cash paid for interest 135,980 39,838    
Non-cash transactions        
Right-of-use assets obtained in exchange for operating lease liabilities 790,615 653,663    
Right-of-use assets obtained in exchange for finance lease liabilities 682,365    
Deferred equity issuance costs 2,769,039    
Issuance of Class A common stock to vendors 891,035    
Issuance of Class A common stock to backstop investors 1,569,463    
Issuance of Class A common stock for services 255,485    
Preferred dividends 9,007,034    
Esgen Acquisition Corp        
Cash Flows from Operating Activities        
Net (loss) income     (3,001,194) 14,334,250
Adjustment to reconcile net (loss) income to cash (used in) provided by operating activities        
Recovery of deferred offering costs allocated to warrants     (425,040)
Change in fair value of warrant liabilities     317,376 (13,179,936)
Changes in operating assets and liabilities:        
Due to related party     195,000 545,405
Prepaid assets     11,831 1,455,576
Accounts payable and accrued expenses     3,802,357 120,000
Net cash (used in) provided by operating activities     900,330 3,275,295
Cash flows from Investing Activities        
Extension funding used to purchase marketable securities and cash held in Trust Account     (1,116,710)
Cash withdrawn from Trust Account in connection with redemptions     272,554,813
Proceeds from sale of marketable securities deposited into cash held in Trust Account     15,862,501
Reinvestment of marketable securities and cash held in Trust Account     (1,794,036) (3,984,431)
Net cash used in investing activities     285,506,568 (3,984,431)
Cash flows from Financing Activities        
Proceeds from note payable-related party     1,612,398
Redemptions of Class A ordinary shares subject to possible redemption     (272,554,813)
Net cash provided by (used in) financing activities     (270,942,415)
Net (decrease) increase in cash and cash equivalents     15,464,483 (709,136)
Cash and cash equivalents, beginning of period $ 60,518 $ 614,767 614,767 1,323,903
Cash and cash equivalents, end of the period     60,518 614,767
Cash held in Trust Account     16,018,732
Total cash and cash in Trust Account     16,079,250 614,767
Supplemental disclosure of cash flow information:        
Change in value of Class A ordinary shares subject to possible redemption     3,066,977 3,986,568
Impact of the waiver of deferred commission by the underwriters     9,234,960
Conversion of Class B ordinary shares to Class A ordinary shares     $ 562